Renaissance Acquisition Holdings focuses on two pharmaceutical industry segments in the United States: 1) contract development and manufacturing, and 2) commercialization of generic sterile and niche prescription products.
Renaissance’s Contract Development and Manufacturing segment operates out of a state-of-the-art, 310,000 square foot facility in Lakewood, New Jersey. The Company’s capabilities include development and manufacturing across nasal, ophthalmic, otic, sub-lingual, and other sterile dosage forms. The Lakewood facility offers aseptic processing and terminal sterilization capabilities, and has on-site, fully-integrated QC, spray characterization and testing, micro testing, and biotech laboratories.
Renaissance’s Commercial Operations unit is located in Newtown, Pennsylvania, and is focused on marketing generic, niche products with substantial barriers to entry.